NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HG-23-010 from the NIH Guide for Grants and Contracts
Notice NOT-HG-23-011 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-009 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AT-23-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support a collection of research networks that promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will guide future clinical research on MBIs in these health conditions effectively, adopt consistent terminology and taxonomy, support interdisciplinary collaborations, initiate pilot projects testing novel mechanistic hypotheses, and identify strong mechanistic measures, outcomes, biomarkers, as well as relevant novel technologies and methodologies. To accomplish these objectives, applicants can propose activities such as meetings, workshops, conferences, research collaborations, exchange of ideas through visiting scientist arrangements and training opportunities. The research networks would also provide opportunities for development of pilot projects addressing research gaps identified through network meetings and collaborative discussions, providing the necessary preliminary data needed for music and health investigators to compete for more substantial NIH grants. In addition, the networks should also engage in dissemination activities that promote and sustain their scientific impact through publications of research frameworks, common terminologies, reviews, and best practices as well as other outreach and communication strategies.
Notice NOT-CA-22-136 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-004 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-23-029 from the NIH Guide for Grants and Contracts. The National Center for Medical Rehabilitation Research (NCMRR) Early Career Research (ECR) Award (R03) is intended to support both basic and clinical research from rehabilitation scientists who are establishing independent research careers. The research must be focused on one or more of the areas within the mission of NCMRR: Applicants are encouraged to refer to the NIH Research Plan on Rehabilitation for strategic priorities (https://www.nichd.nih.gov/newsroom/news/110121-NIH-rehab-plan). The NCMRR ECR Award R03 grant mechanism supports various types of projects including secondary analysis of existing data; small, self-contained research projects; development of research methodology; translational research; outcomes research; and development of new technology. Irrespective of the type of project, the intent of the NCMRR ECR Award R03 is for the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) to obtain sufficient preliminary data for a subsequent R01 application.
Notice NOT-EY-22-017 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-006 from the NIH Guide for Grants and Contracts
Notice NOT-CA-23-005 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-033 from the NIH Guide for Grants and Contracts
Notice NOT-AG-22-042 from the NIH Guide for Grants and Contracts
Notice NOT-AG-22-041 from the NIH Guide for Grants and Contracts
Notice NOT-AG-22-040 from the NIH Guide for Grants and Contracts
Notice NOT-DA-22-081 from the NIH Guide for Grants and Contracts
Notice NOT-HG-23-004 from the NIH Guide for Grants and Contracts
Notice NOT-TR-22-037 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-HL-24-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit current or recently completed NHLBI K01, K08, K23, and K25 awardees for small grant support to expand their current research objectives or to branch out to a new study that resulted from the research conducted under the K award. Active NHLBI K01, K08, K23, and K25 awardees may apply for R03 support after the notices of award (NoA) for their first type-5 K awards have been issued. Recently completed NHLBI K01, K08, K23, and K25 awardees are eligible to apply for the R03 if the earliest possible R03 start date falls within 2 years of their prior NHLBI K award Project Period end date. This FOA is intended to enhance the capability of NHLBI K01, K08, K23, and K25 awardees to conduct research as they complete their transition to fully independent investigator status. This R03 grant mechanism is intended to support research projects that can be carried out and completed within a short period of time (no more than two years) with limited resources and that may generate preliminary data to support a subsequent R01-equivalent application. These studies include, but not limited to, pilot or feasibility studies; proof of concept studies; secondary analysis of existing data; small, self-contained research projects; development of new research methodologies or technologies, or development of novel experimental models. For current and previous K23 awardees, research proposed in the R03 application may or may not include patient-oriented research. A minimum of 40% protected overall research effort is required from applicants during the R03 award period and can be met through a combination of effort on the proposed R03 and other research projects, regardless of funding source.
Funding Opportunity PAR-22-247 from the NIH Guide for Grants and Contracts. The INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project encourages grant applications aimed at developing, characterizing, or improving animal models and related biological materials for Down syndrome (DS) related research and improving access to information about or from the use of animal models for DS research. The animal models and related biological materials developed must have utility in targeted or basic science studies in areas highly relevant to DS. With this funding opportunity announcement, the INCLUDE Project encourages, but is not limited to, projects focusing on development of various animal models, genetic resources, atlases at a single cell or subcellular level, advanced informatics technologies including artificial intelligence (AI) or machine learning (ML), and integration of multiple animal models and technology platforms for enhancing rigor and reproducibility of preclinical DS research.
Funding Opportunity RFA-DE-23-013 from the NIH Guide for Grants and Contracts. The goal of this FOA is to accelerate translation of research to improve early detection of head and neck cancers (HNC). This initiative will encourage development, evaluation, and validation of biomarkers for risk assessment, detection, and molecular diagnosis and prognosis of early HNC.